OUTCOME AFTER SBRT FOR POTENTIALLY OPERABLE NSCLC PATIENTS

被引：0
|
作者：
Rossi, M. [1 ]
Peulen, H. [1 ]
van Tinteren, H. [2 ]
Wouters, M. [3 ]
Sonke, J. -J. [1 ]
Baas, P. [4 ]
Smit, E. F. [4 ]
Belderbos, J. [1 ]
机构：
[1] Netherlands Canc Inst, Radiotherapy, Amsterdam, Netherlands
[2] Netherlands Canc Inst, Biometr Dept, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Surg Oncol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Thorac Oncol, Amsterdam, Netherlands
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
10.1093/annonc/mdv048.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
71P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] OPTIMIZING SBRT TREATMENT DELIVERY FOR NSCLC
    Brock, J.
    Nioutsikou, E.
    Ashley, S.
    Bedford, J.
    McNair, H.
    Aitken, A.
    Brada, M.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S73 - S73
  • [42] Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma
    van Dijkum, EJM
    Terwee, CB
    Oosterveld, P
    van der Meulen, JHP
    Gouma, DJ
    de Haes, JCJM
    BRITISH JOURNAL OF SURGERY, 2000, 87 (01) : 110 - 115
  • [43] Salvage SBRT for postoperative recurrence of NSCLC
    Aoki, S.
    Yamashita, H.
    Takahashi, W.
    Nawa, K.
    Ota, T.
    Nozawa, Y.
    Ozaki, S.
    Nakamoto, T.
    Nakagawa, K.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S743 - S743
  • [44] SBRT for oligoprogressive oncogene addicted NSCLC
    Basler, L.
    Kroeze, S. G. C.
    Guckenberger, M.
    LUNG CANCER, 2017, 106 : 50 - 57
  • [45] Physical behavior and associations with health outcomes in operable NSCLC patients: A prospective study
    Timmerman, J. G.
    Dekker-van Weering, M. G. H.
    Wouters, M. W. J. M.
    Stuiver, M. M.
    de Kanter, W.
    Vollenbroek-Hutten, M. M. R.
    LUNG CANCER, 2018, 119 : 91 - 98
  • [46] Randomized Phase II Study of Pembrolizumab after SBRT versus Pembrolizumab Alone in Patients with Advanced NSCLC, Preliminary Results
    Theelen, Willemijn
    Lalezari, Ferry
    Van Den Heuvel, Michel
    Baas, Paul
    Peulen, Heike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1453 - S1453
  • [47] Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence?
    Guckenberger, Matthias
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (05) : 525 - 530
  • [48] Is stereotactic body radiotherapy an alternative to surgery in operable patients with stage I NSCLC?
    Dahele, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S230 - S231
  • [49] Targeted adjuvant: First Data on Alectinib in Patients with operable ALK plus NSCLC
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (05)
  • [50] Influence of PTV underdosage on local control in patients with central NSCLC treated with SBRT
    Duijm, M.
    Van der Voort van Zyp, N.
    Granton, P.
    Van de Vaart, P.
    Mast, M.
    Oomen-de Hoop, E.
    Hoogeman, M.
    Nuyttens, J.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S536 - S536
12345